{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:04:36Z","timestamp":1791291876533,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.tiv.2013.10.025","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T07:33:50Z","timestamp":1383982430000},"page":"258-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Feasibility of a 3D human airway epithelial model to study respiratory absorption"],"prefix":"10.1016","volume":"28","author":[{"given":"Astrid A.","family":"Reus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred J.M.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm T.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Constant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne C.M.","family":"Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos J.","family":"van Triel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Frieke","family":"Kuper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2013.10.025_b0005","unstructured":"2003\/15\/EC, 2003. Directive 2003 of the European Parliament and of the Council of 27 February 2003. amending Council Directive 76\/78\/EEC on the approximation of the laws of the Member States relating to cosmetic products. Off. J. Eur. Union 46, pp. 26\u201335."},{"key":"10.1016\/j.tiv.2013.10.025_b0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000265681","article-title":"The Phenion full-thickness skin model for percutaneous absorption testing","volume":"23","author":"Ackermann","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.tiv.2013.10.025_b0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.tiv.2012.11.017","article-title":"Toxicological analysis of limonene reaction products using an in vitro exposure system","volume":"27","author":"Anderson","year":"2013","journal-title":"Toxicol. In Vitro"},{"issue":"suppl. 1","key":"10.1016\/j.tiv.2013.10.025_b0180","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1089\/dia.2007.0228","article-title":"Inhalation, deposition and fate of insulin and other therapeutic proteins","volume":"9","author":"Brain","year":"2007","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.tiv.2013.10.025_b0185","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11095-011-0443-4","article-title":"Insulin lung deposition and clearance following Technosphere\u00ae insulin inhalation powder administration","volume":"28","author":"Cassidy","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2013.10.025_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/toxsci\/55.1.24","article-title":"Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations","volume":"55","author":"Driscoll","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2013.10.025_b0025","unstructured":"EC 1907\/2006, 2006. Regulation (EC) No 1907\/2006 of the European Parliament and the Council of 18 December 2006, concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), establishing a European Chemical Agency, amending Directive 1999\/45\/EC and repealing Council Regulation (EEC) No 793\/03 and Commission Regulation (EC) No 1488\/94 as well as Council Directive 76\/769\/EEC and Commission Directives 91\/155\/EC, 93\/67\/EC, 93\/105\/EC and 2000\/21\/EC. Off. J. Eur. Union 49, pp. 1\u2013849."},{"key":"10.1016\/j.tiv.2013.10.025_b0030","unstructured":"FDA, 2000. Guidance for industry. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), August 2000, BP."},{"key":"10.1016\/j.tiv.2013.10.025_b0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2005.02.010","article-title":"Human respiratory epithelial cell culture for drug delivery applications","volume":"60","author":"Forbes","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2013.10.025_b0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(03)00129-7","article-title":"The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport","volume":"257","author":"Forbes","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2013.10.025_b0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.clpt.6100286","article-title":"Effect of upper respiratory tract infection on AIR inhaled insulin pharmacokinetics and glucodynamics in healthy subjects","volume":"83","author":"Gern","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2013.10.025_b0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/jam.2006.19.522","article-title":"Lung deposition of mannitol powder aerosol in healthy subjects","volume":"19","author":"Glover","year":"2006","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.tiv.2013.10.025_b0195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijpharm.2007.08.013","article-title":"Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers","volume":"349","author":"Glover","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2013.10.025_b0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/rmed.2002.1457","article-title":"Fundamentals of pulmonary drug delivery","volume":"97","author":"Groneberg","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.tiv.2013.10.025_b0050","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tiv.2013.10.025_b0055","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2337\/diacare.26.3.764","article-title":"Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects","volume":"26","author":"Henry","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tiv.2013.10.025_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.toxlet.2009.03.019","article-title":"Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model","volume":"188","author":"Hu","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2013.10.025_b0065","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.tiv.2012.10.010","article-title":"Potential of in vitro reconstituted 3D human airway epithelia (MucilAir\u2122) to assess respiratory sensitizers","volume":"27","author":"Huang","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2013.10.025_b0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/ers.11.87","article-title":"Inhaled mannitol for the treatment of cystic fibrosis","volume":"6","author":"Hurt","year":"2012","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.tiv.2013.10.025_b0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.12.014","article-title":"Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer","volume":"354","author":"Kavimandan","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2013.10.025_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/026119291103900410","article-title":"In-house validation of the EpiOcular\u2122 eye irritation test and its combination with the bovine corneal opacity and permeability test for the assessment of ocular irritation","volume":"39","author":"Kolle","year":"2011","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.tiv.2013.10.025_b0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/jpp.58.2.0016","article-title":"Paracellular and transcellular pathways facilitate insulin permeability in rat gut","volume":"58","author":"Lane","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tiv.2013.10.025_b0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2125.1994.tb04309.x","article-title":"Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat","volume":"37","author":"Lennern\u00e4s","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2013.10.025_b0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jps.20803","article-title":"Air\u2013liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies","volume":"96","author":"Lin","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2013.10.025_b0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI113938","article-title":"Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers","volume":"83","author":"Madara","year":"1989","journal-title":"J Clin. Invest."},{"key":"10.1016\/j.tiv.2013.10.025_b0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1600-0668.2011.00727.x","article-title":"Inhalation exposure of children to fragrances present in scented toys","volume":"21","author":"Masuck","year":"2011","journal-title":"Indoor Air"},{"key":"10.1016\/j.tiv.2013.10.025_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10611860290007504","article-title":"Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro\u2013in vivo correlation to predict lung absorption in rats","volume":"10","author":"Mathias","year":"2002","journal-title":"J. Drug Target"},{"key":"10.1016\/j.tiv.2013.10.025_b0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/jes.2011.10","article-title":"Potential for exposure to engineered nanoparticles from nanotechnology-based consumer spray products","volume":"21","author":"Nazarenko","year":"2011","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.tiv.2013.10.025_b0125","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1012111008617","article-title":"Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model","volume":"14","author":"Pade","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2013.10.025_b0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-61779-120-8_18","article-title":"Primary epithelial cell models for cystic fibrosis research","volume":"742","author":"Randell","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2013.10.025_b0135","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dc06-2284","article-title":"AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability","volume":"30","author":"Rave","year":"2007","journal-title":"Diabetes Care"},{"issue":"55","key":"10.1016\/j.tiv.2013.10.025_b0140","first-page":"e3261","article-title":"Use of the EpiAirway model for characterizing long-term host-pathogen interactions","volume":"2","author":"Ren","year":"2011","journal-title":"J. Vis. Exp. Sep."},{"key":"10.1016\/j.tiv.2013.10.025_b0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tiv.2012.10.007","article-title":"In vivo\u2013in vitro comparison of acute respiratory tract toxicity using human 3D airway epitelial models and human A549 and murine 3T3 monolayer cell systems","volume":"27","author":"Sauer","year":"2013","journal-title":"Toxicol. In Vitro"},{"issue":"Suppl 1","key":"10.1016\/j.tiv.2013.10.025_b0150","first-page":"101","article-title":"Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine)","volume":"30","author":"Smetanova","year":"2009","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.tiv.2013.10.025_b0155","first-page":"943982","article-title":"Evaluation of differentiated human bronchial epithelial cell culture systems for asthma research","volume":"2","author":"Stewart","year":"2012","journal-title":"J. Allergy (Cairo)"},{"key":"10.1016\/j.tiv.2013.10.025_b0160","first-page":"3384","article-title":"Receptor-mediated endocytosis and intracellular trafficking of insulin and low-density lipoprotein by retinal vascular endothelial cells","volume":"35","author":"Stitt","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tiv.2013.10.025_b0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14656566.2012.638917","article-title":"The use of inhaled mannitol in the diagnosis and management of asthma","volume":"13","author":"Sverrild","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.tiv.2013.10.025_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2011.04.003","article-title":"Facilitated nanoscale delivery of insulin across intestinal membrane models","volume":"412","author":"Woitiski","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2013.10.025_b0175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/dc07-0873","article-title":"AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma","volume":"31","author":"Wolzt","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:29:54Z","timestamp":1564648194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233313002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0887233313002804"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2013.10.025","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of a 3D human airway epithelial model to study respiratory absorption","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2013.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}